Jaime Nicole Dutton, MD
General Surgery · Fayetteville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Roller Weight Loss Institute, Inc. · 24 clinicians in this group
Hospitals listed: Northwest Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Dutton’s office at (479) 445-6460 to ask if they take your plan before you enroll.
California Medical Board record
Licence A148716 · Cancelled
Licence status: Cancelled · since 2017 · University of Kansas School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Northwest Medical Center-SpringdaleSpringdale, ARAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Community Health Systems, which runs 81 hospitals in 15 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.4 (1.1 to 1.8) · 526 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.051, Oct 2024 – Sep 2025
See every measure and the patient survey for Northwest Medical Center-Springdale
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 4 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.4 (1.1 to 1.8) · 526 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.051 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.13 to 2.14) · 720 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.93 (0.58 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.46 (157.57 to 265.36) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.9 · 158 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.6 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.3 · 268 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16.2 · 83 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 1,869 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,715 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 3,755 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.31 (1.05 to 5.57) · 956 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.35 (0 to 2.9) · 442 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.09 (0.56 to 3.63) · 955 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.76 (5.52 to 20) · 438 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.86 (1.38 to 8.34) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.23) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.24 (0 to 1.07) · 2,628 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.623 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.642 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.013 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.48 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 253 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 351 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -15.7 · 170 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -41.4 · 216 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -32.2 · 286 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 409 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 243 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.9 to 17.4) · 609 cases | No different | Jan 2022 – Dec 2024 |
What patients said (1,176 patients answered, 13% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$44,353
Medicare paid this office $44,353 for 90 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $1,733 | $75 |
| New patient visit (30+ min) | 22 | $1,621 | $74 |
| Short return visit | 18 | $882 | $37 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Hernia repair (minimally invasive) | 1-10 | None |
| Removal of tissue | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 43 | More than 61% of doctors who do this |
Who their Medicare patients are
90 Original Medicare patients in 2024. Average age 68 · Under 65 24% · Women 63% · Also on Medicaid 17% · Health risk score 1.63. At or below the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 75% · Depression 47% · Diabetes 40% · Chronic kidney disease 37% · Coronary heart disease 32% · COPD 24% · Heart failure 23% · Atrial fibrillation 20% · Cancer 17%.
The office billed $551,667, Medicare allowed $56,546 and paid $44,353; for 157 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 90 | 157 | 68 | 1.63 | $551,667 | $44,353 |
| 2023 | 118 | 177 | 65 | 1.39 | $294,197 | $50,369 |
| 2022 | 164 | 280 | 64 | 1.38 | $627,700 | $116,932 |
| 2021 | 115 | 188 | 63 | 1.11 | $366,465 | $71,553 |
| 2020 | 169 | 313 | 62 | 1.11 | $587,600 | $114,821 |
| 2019 | 102 | 156 | 63 | 1.23 | $323,595 | $61,748 |
| 2018 | 38 | 50 | 69 | 1.64 | $90,955 | $9,057 |
| 2017 | 13 | 17 | 65 | 1.44 | $35,561 | $2,034 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Partial removal of stomach, upper bowel, and ileum for weight loss | 14 | $18,491 | $1,321 |
| Diagnostic exam of esophagus using a flexible endoscope through nose | 31 | $3,909 | $126 |
| New patient visit (30+ min) | 18 | $1,442 | $80 |
| Return visit (30+ min) | 15 | $1,033 | $69 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,014 | $78 |
| Short return visit | 17 | $698 | $37 |
2022: 9 services
| Other procedure on stomach using an endoscope | 35 | $48,502 | $1,347 |
| Bypass of stomach using an endoscope | 13 | $16,631 | $1,279 |
| Diagnostic exam of esophagus using a flexible endoscope through nose | 47 | $6,139 | $128 |
| Removal of gallbladder using an endoscope | 11 | $5,302 | $482 |
| Return visit (30+ min) | 48 | $2,653 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,318 | $101 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,273 | $91 |
| New patient visit (30+ min) | 13 | $991 | $76 |
| Short return visit | 15 | $662 | $39 |
2021: 6 services
| Other procedure on stomach using an endoscope | 18 | $24,629 | $1,296 |
| Removal of gallbladder using an endoscope | 14 | $6,316 | $451 |
| Diagnostic exam of esophagus using a flexible endoscope through nose | 27 | $3,481 | $129 |
| Return visit (30+ min) | 24 | $1,996 | $83 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,384 | $73 |
| Short return visit | 13 | $522 | $35 |
2020: 8 services
| Other procedure on stomach using an endoscope | 35 | $49,904 | $1,426 |
| Bypass of stomach using an endoscope | 17 | $21,588 | $1,270 |
| Diagnostic exam of esophagus using a flexible endoscope through nose | 64 | $8,159 | $127 |
| Removal of gallbladder using an endoscope | 14 | $6,879 | $491 |
| Return visit (30+ min) | 56 | $4,491 | $79 |
| New patient visit (30+ min) | 13 | $956 | $74 |
| Short return visit (20+ min) | 14 | $774 | $52 |
| Short return visit | 11 | $325 | $30 |
2019: 3 services
| Bypass of stomach using an endoscope | 21 | $27,420 | $1,306 |
| Diagnostic exam of esophagus using a flexible endoscope through nose | 45 | $6,224 | $135 |
| Return visit (30+ min) | 26 | $2,044 | $79 |
Medicaid work
$9,256 in 2023
Medicaid paid $9,256 for 51 billed services this clinician did in 2023, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Diagnostic transnasal flexible esophagoscopy | 51 | $9,256 |
| 2023 | 51 | 1 | 18 | $9,256 |
| 2022 | 82 | 1 | 17 | $11,733 |
| 2020 | 19 | 1 | 19 | $4,213 |
See the largest Medicaid services in earlier years
2022
| Diagnostic transnasal flexible esophagoscopy | 82 | $11,733 |
2020
| Diagnostic transnasal flexible esophagoscopy | 19 | $4,213 |
Drugs they prescribed that Part D paid
$5,885
Pharmacies billed $5,885 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 20% of their Part D prescriptions (68 of 333) in 2024. At or below the middle of the specialty; the typical general surgery clinician is at 34%.
313 generic and 20 brand-name prescriptions · $5,885 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Omeprazole | 95 | $1,573 | $17 |
| Misoprostol | 27 | $1,504 | $56 |
| Sucralfate | 21 | $451 | $21 |
| Hydrocodone-Acetaminophen | 61 | $384 | $6 |
| Pantoprazole | 60 | $274 | $5 |
See all 6 drugs
| Omeprazole | 95 | $1,573 | $17 |
| Misoprostol | 27 | $1,504 | $56 |
| Sucralfate | 21 | $451 | $21 |
| Hydrocodone-Acetaminophen | 61 | $384 | $6 |
| Pantoprazole | 60 | $274 | $5 |
| Promethazine | 17 | $77 | $5 |
Year by year
| 2024 | 333 | 115 | 20% (68) | 6% | $5,885 |
| 2023 | 381 | 126 | 17% (66) | None | $10,598 |
| 2022 | 546 | 166 | 14% (75) | 5% | $20,151 |
| 2021 | 787 | 167 | 11% (83) | None | $15,846 |
| 2020 | 645 | 177 | 19% (122) | None | $11,195 |
| 2019 | 261 | 86 | 20% (53) | 4% | $9,491 |
| 2018 | 93 | 59 | 44% (41) | 17% | $4,333 |
| 2017 | 68 | 36 | 29% (20) | 19% | $6,203 |
| 2016 | 12 | None | None | None | $415 |
| 2015 | 16 | None | None | None | $437 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Misoprostol | 47 | $4,522 | $96 |
| Omeprazole | 117 | $1,724 | $15 |
| Pantoprazole | 55 | $1,074 | $20 |
| Hydrocodone-Acetaminophen | 57 | $374 | $7 |
| Ondansetron Odt | 20 | $282 | $14 |
| Promethazine | 37 | $153 | $4 |
2022: 7 drugs
| Misoprostol | 48 | $6,270 | $131 |
| Omeprazole | 198 | $3,385 | $17 |
| Pantoprazole | 74 | $1,415 | $19 |
| Sucralfate | 25 | $689 | $28 |
| Hydrocodone-Acetaminophen | 67 | $449 | $7 |
| Ondansetron Odt | 16 | $317 | $20 |
| Promethazine | 63 | $257 | $4 |
2021: 7 drugs
| Omeprazole | 393 | $4,702 | $12 |
| Misoprostol | 30 | $3,544 | $118 |
| Pantoprazole | 58 | $1,226 | $21 |
| Hydrocodone-Acetaminophen | 71 | $675 | $10 |
| Promethazine | 107 | $489 | $5 |
| Ondansetron Odt | 28 | $441 | $16 |
| Ondansetron | 13 | $129 | $10 |
2020: 7 drugs
| Misoprostol | 44 | $4,027 | $92 |
| Omeprazole | 257 | $2,462 | $10 |
| Hydrocodone-Acetaminophen | 102 | $976 | $10 |
| Pantoprazole | 77 | $880 | $11 |
| Ondansetron | 20 | $262 | $13 |
| Promethazine | 69 | $259 | $4 |
| Ondansetron Odt | 14 | $157 | $11 |
2019: 5 drugs
| Misoprostol | 34 | $4,415 | $130 |
| Omeprazole | 55 | $661 | $12 |
| Hydrocodone-Acetaminophen | 42 | $424 | $10 |
| Pantoprazole | 44 | $364 | $8 |
| Promethazine | 25 | $68 | $3 |
2018: 2 drugs
| Hydrocodone-Acetaminophen | 31 | $517 | $17 |
| Pantoprazole | 16 | $209 | $13 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 14 | $578 | $41 |
Money from drug and device companies
$148 in 2025
| 2025 | 2 | 5 | None | $148 |
| 2024 | 4 | 10 | None | $477 |
| 2023 | 3 | 9 | None | $180 |
| 2022 | 4 | 18 | None | $425 |
| 2021 | 7 | 11 | None | $196 |
| 2020 | 5 | 18 | None | $9,249 |
| 2019 | 8 | 21 | None | $2,088 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vertex Pharmaceuticals | Journavx | $91 | 4 payments
|
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $57 | 1 payment
|
See all 5 published payments
| Vertex Pharmaceuticals | Meals · 2025-12-16 | Journavx | $21 |
| TELA Bio | Meals · 2025-11-17 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $57 |
| Vertex Pharmaceuticals | Meals · 2025-11-12 | Journavx | $21 |
| Vertex Pharmaceuticals | Meals · 2025-10-14 | Journavx | $20 |
| Vertex Pharmaceuticals | Meals · 2025-09-09 | Journavx | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $477
| Baxter Healthcare | Adept | $375 | 7 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $63 | 1 payment
|
| Olympus America | Olympus | $20 | 1 payment
|
| Conmed | Airseal | $19 | 1 payment
|
2023: $180
| Baxter Healthcare | Recothrom | $148 | 7 payments
|
| Novo Nordisk | None | $18 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Gattex | $14 | 1 payment
|
2022: $425
| Baxter Healthcare | Adept | $208 | 13 payments
|
| Medtronic | Signia | $188 | 3 payments
|
| Teleflex | Quikclot | $18 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $12 | 1 payment
|
2021: $196
| Avanos Medical | On-Q* Pump and Accessories | $36 | 1 payment
|
| Novo Nordisk | Wegovy | $36 | 2 payments
|
| W. L. Gore & Associates | Seamguard | $32 | 2 payments
|
| Medtronic | Ligasure | $30 | 2 payments
|
| Endo Pharmaceuticals | Nascobal | $26 | 2 payments
|
| Davol | Phasix | $19 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Gattex | $17 | 1 payment
|
2020: $9,249
| Intuitive Surgical | Da Vinci Surgical System | $9,093 | 13 payments
|
| Avanos Medical | On-Q* Pump and Accessories | $104 | 1 payment
|
| Endo Pharmaceuticals | Nascobal | $25 | 2 payments
|
| Currax Pharmaceuticals | Contrave | $15 | 1 payment
|
| Novo Nordisk | Saxenda | $12 | 1 payment
|
2019: $2,088
| Intuitive Surgical | Da Vinci Surgical System | $1,570 | 7 payments
|
| Covidien LP | Sonicision | $341 | 7 payments
|
| Acell | None | $82 | 1 payment
|
| Baxter Healthcare | Peri-Strips Dry | $32 | 1 payment
|
| Novo Nordisk | Saxenda | $26 | 2 payments
|
| Apollo Endosurgery US | Overstitch | $17 | 1 payment
|
| Shire North American Group | Gattex | $14 | 1 payment
|
| Bolder Surgical | Justright Sealer | $4 | 1 payment
|
Professional record
- NPI
- 1861611725
- Licence
- CA A148716California A148716: Cancelled
- Trained
- University of Kansas School of Med (Kc/Wich/Sal), 2012
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr Rm H3591, Stanford, CA, 94305
- NPI first listed
- 2007-04-25
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.